Valeris Leads New Innovations in Patient Affordability
Valeris, known as a comprehensive life sciences commercialization partner, is making headlines with its latest achievement in redefining patient affordability in the healthcare landscape. The Valeris Patient Affordability team is tackling the challenges posed by medical benefit maximizers, a growing concern that many affordability solutions have yet to fully address. This innovative approach signals a major step forward in the relentless pursuit of improving patient access to medicines.
Understanding Medical Benefit Maximizers
While many organizations in the patient affordability space are aware of issues surrounding pharmacy benefit maximizers, the new tactics emerging within medical benefits have raised significant concerns. Medical benefit maximizers can impose considerable barriers on patients, yet few are adequately prepared to recognize or counteract these strategies. Valeris sets itself apart by acknowledging this vital aspect of patient support.
Leveraging Innovative Technology
Central to Valeris's strategy is its proprietary Policy Reporter™ technology, which acts as a groundbreaking tool that allows for the identification of plan administrators targeting specific medications within medical benefit maximizer plans. This technological advantage provides Valeris with an edge, helping them to pinpoint the drugs most affected and enable timely interventions.
Proactive Measures for Patient Support
According to Michael Harris, Vice President of Patient Support Services Strategy at Valeris, the company's medical benefit copay technology allows for the identification of patients at risk. "We can take various steps to disrupt the plans that affect them," Harris states. In fact, with these insights, the team has identified 200 brands currently impacted by such health plan designs. This proactive approach aims to prevent the complications that could arise if these maximizer tactics began echoing the challenges faced within the pharmacy benefit area.
Engaging with Manufacturers to Mitigate Challenges
Valeris invites manufacturers looking to protect their brands and the interests of patients to engage with their Patient Affordability team. They aim to reveal emerging payer tactics and suggest effective strategies to address these challenges before they escalate into widespread disruption. The proactive stance taken by Valeris not only aids in safeguarding manufacturers but also ensures that patients receive uninterrupted access to the medications they require.
Looking Ahead: Innovations on the Horizon for Valeris
The year ahead looks promising for Valeris, as initial measures are already being implemented, with further enhancements planned to benefit various stakeholders involved. As these advancements unfold, Valeris remains committed to transforming the patient experience by alleviating the financial burdens associated with acquiring essential pharmaceuticals.
About Valeris
Valeris is recognized as a fully integrated life sciences commercialization partner dedicated to providing a range of solutions that traverse the healthcare value chain. The company focuses on enhancing patient experiences to ensure that critical medications are accessible and that patients can adhere to their treatment plans. With a reputation built on proven industry expertise, a strong dedication to patient care, cutting-edge technology, and an exceptionally talented team, Valeris provides valuable data and insights, patient support services, and engagement tools. Serving over 500 life sciences partners, Valeris has successfully helped millions of patients achieve access and affordability in medication management.
Contact Information
For inquiries, individuals can reach out to:
Landy Townsend
VP, Marketing & Communications
Valeris
Frequently Asked Questions
What is Valeris known for?
Valeris is a life sciences commercialization partner specializing in patient affordability and access to critical medications.
How does Valeris address medical benefit maximizers?
The company utilizes proprietary technology to identify affected patients and disrupt plans that may hinder their access to medications.
Why are medical benefit maximizers a concern?
These tactics can significantly impact patients by increasing financial barriers to accessing necessary medications.
Who can manufacturers contact for support?
Manufacturers can engage with the Valeris Patient Affordability team for insights into payer tactics and response strategies.
What does the future hold for Valeris?
Valeris is focused on innovations and enhancements to improve patient experiences further in the coming year.
